Hyaluronic acid modified pH-sensitive liposomes for targeted intracellular delivery of doxorubicin

Journal of Liposome Research

Volumn 26, Issue 4, 2016, Pages 276-287

  Paliwal, Shivani Rai ^a,b   Paliwal, Rishi ^b,c   Agrawal, Govind Prasad ^b   Vyas, Suresh Prasad ^b  

^a GURU GHASIDAS UNIVERSITY   (India)

^b DR H S GOUR UNIVERSITY   (India)

^c Department of Pharmaceutical Analysis and Quality Assurance   (India)

Author keywords

Breast cancer; CD44 receptors; doxorubicin; hyaluronic acid; targeting

Indexed keywords

CREATINE KINASE; DOXORUBICIN; DRUG CARRIER; HERMES ANTIGEN; HYALURONAN RECEPTOR; HYALURONIC ACID; LACTATE DEHYDROGENASE; LIPOSOME; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; ANTINEOPLASTIC ANTIBIOTIC;

ACIDITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CARDIOTOXICITY; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; DRUG ACCUMULATION; DRUG CLEARANCE; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG EFFECT; DRUG EFFICACY; DRUG FORMULATION; DRUG MECHANISM; DRUG POTENCY; DRUG RELEASE; DRUG SCREENING; DRUG UPTAKE; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; IC50; IN VITRO STUDY; LACTATE DEHYDROGENASE BLOOD LEVEL; MCF 7 CELL LINE; MOUSE; NONHUMAN; PH; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SINGLE DRUG DOSE; SURFACE PROPERTY; TISSUE DISTRIBUTION; TUMOR XENOGRAFT; ZETA POTENTIAL; ANIMAL; BAGG ALBINO MOUSE; BLOOD; CELL PROLIFERATION; CHEMISTRY; DOSE RESPONSE; DRUG EFFECTS; MAMMARY NEOPLASMS, EXPERIMENTAL; MCF-7 CELL LINE; PATHOLOGY; STRUCTURE ACTIVITY RELATION; TUMOR CELL CULTURE;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; CELL PROLIFERATION; CREATINE KINASE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXORUBICIN; DRUG DELIVERY SYSTEMS; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; HUMANS; HYALURONIC ACID; HYDROGEN-ION CONCENTRATION; L-LACTATE DEHYDROGENASE; LIPOSOMES; MAMMARY NEOPLASMS, EXPERIMENTAL; MCF-7 CELLS; MICE; MICE, INBRED BALB C; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR CELLS, CULTURED;

EID: 84954509352     PISSN: 08982104     EISSN: 15322394     Source Type: Journal    
DOI: 10.3109/08982104.2015.1117489     Document Type: Article

References (46)

1. K.Akima, H.Ito, Y.Iwata,. (1996). Evaluation of antitumor activities of hyaluronate binding antitumor drugs:synthesis, characterization and antitumor activity. J Drug Target 4:1–8
2. Z.S.Al-Ahmady, W.T.Al-Jamal, J.V.Bossche,. (2012). Lipid-peptide vesicle nanoscale hybrids for triggered drug release by mild hyperthermia in vitro and in vivo. ACS Nano 6:9335–46
3. J.Z.Du, X.J.Du, C.Q.Mao,. (2011). Tailor-made dual pH-sensitive polymer-doxorubicin nanoparticles for efficient anticancer drug delivery. J Am Chem Soc 133:17560–3
4. T.A.Elbayoumi, V.P.Torchilin (2010). Current trends in liposome research. Methods Mol Biol 605:1–27
5. R.E.Eliaz, S.Nir, C.Marty, F.C.SzokaJr.(2004). Determination and modeling of kinetics of cancer cell killing by doxorubicin and doxorubicin encapsulated in targeted liposomes. Cancer Res 64:711–8
6. R.E.Eliaz, F.C.SzokaJr.(2001). Liposome-encapsulated doxorubicin targeted to CD44:a strategy to kill CD44-overexpressing tumor cells. Cancer Res 61:2592–601
7. H.Ellens, J.Bentz, F.C.Szoka (1984). pH-induced destabilization of phosphatidylethanolamine-containing liposomes:role of bilayer contact. Biochemistry 23:1532–8
8. D.W.Fry, J.C.White, I.D.Goldman (1978). Rapid separation of low molecular weight solutes from liposomes without dilution. J Anal Biochem 90:809–15
9. D.A.Gewirtz (1999). A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin. Biochem Pharmacol 57:727–41
10. V.Gouaze, M.E.Mirault, S.Carpentier,. (2001). Glutathione peroxidase-1 overexpression prevents ceramide production and partially inhibits apoptosis in doxorubicin-treated human breast carcinoma cells. Mol Pharmacol 60:488–96
11. A.Herrera-Gayol, S.Jothy (1999). Adhesion proteins in the biology of breast cancer:contribution of CD44. Exp Mol Pathol 66:149–56
12. M.J.Hope, B.Mui, S.Ansell, Q.F.Ahkong (1998). Cationic lipids, phosphatidylethanolamine and the intracellular delivery of polymeric, nucleic acid based drugs. J Mol Membr Biol 15:1–14
13. T.Ishida, M.J.Kirchmeier, E.H.Moase,. (2001). Targeted delivery and triggered release of liposomal doxorubicin enhances cytotoxicity against human B lymphoma cells. Biochim Biophys Acta 1515:144–58
14. T.Ishida, R.Maeda, M.Ichihara,. (2003). Accelerated clearance of PEGylated liposomes in rats after repeated injections. J Control Release 88:35–42
15. 2 + increase are reciprocally modulated in rat cardiomyocytes. Exp Mol Med 38:535–45
16. K.Kono, T.Igawa, T.Takagishi (1997). Cytoplasmic delivery of calcein mediated by liposomes modified with a pH-sensitive poly(ethylene glycol) derivative. Biochim Biophys Acta 1325:143–54
17. M.Z.Lai, W.J.Vail, F.C.Szoka (1985). Acid- and calcium-induced structural changes in phosphatidylethanolamine membranes stabilized by cholesteryl hemisuccinate. Biochemistry 24:1654–61
18. J.Lesley, V.C.Hascall, M.Tammi, R.Hyman (2000). Hyaluronan binding by cell surface CD44. J Biol Chem 275:267–9
19. Y.Luo G.D.Prestwich (1999). Synthesis and selective cytotoxicity of a hyaluronic acid-antitumor bioconjugate. Bioconjug Chem 10:755–63
20. H.Maeda, J.Wu, T.Sawa,. (2000). Tumor vascular permeability and the EPR effect in macromolecular therapeutics:a review. J Control Release 65:271–84
21. A.Manosroi, L.L.Kongkaneramit, J.Manosroi (2004). Characterization of amphotericin B liposome formulations. Drug Dev Ind Pharm 30:535–43
22. T.Mosmann (1983). Rapid colorimetric assay for cellular growth and survival:application to proliferation and cytotoxicity assays. J Immunol Methods 65:55–63
23. R.Nayar, C.P.S.Tilcock, M.J.Hope,. (1988). N-Succinyldioleoylphosphatidylethanolamine:structural preferences in pure and mixed model membranes. Biochim Biophys Acta 937:31–41
24. S.R.Paliwal, R.Paliwal, N.Mishra,. (2010). A novel cancer targeting approach based on estrone anchored stealth liposome for site-specific breast cancer therapy. Curr Cancer Drug Targets 10:343–53
25. S.R.Paliwal, R.Paliwal, H.C.Pal,. (2012). Estrogen-anchored pH-sensitive liposomes as nanomodule designed for site-specific delivery of doxorubicin in breast cancer therapy. Mol Pharm 9:176–86
26. S.R.Paliwal, R.Paliwal, S.P.Vyas (2013). pH-sensitive liposomes in drug Delivery. In:C.Alvarez-Lorenzo, A.Concheiro, eds. RSC smart materials No. 2. Smart materials for drug delivery. Vol. 1. London:The Royal Society of Chemistry, 80–93
27. V.M.Platt, F.C.SzokaJr.(2008). Anticancer therapeutics:targeting macromolecules and nanocarriers to hyaluronan or CD44, a hyaluronan receptor. Mol Pharm 5:474–86
28. S.Rai, R.Paliwal, B.Vaidya,. (2008). Targeted delivery of doxorubicin via estrone-appended liposomes. J Drug Target 16:455–63
29. N.Rapoport (2007). Physical stimuli-responsive polymeric micelles for anti-cancer drug delivery. Prog Polym Sci 32:962–90
30. L.H.Reddy, R.S.R.Murthy (2004). Pharmacokinetics and biodistribution studies of doxorubicin loaded poly(butyl cyanoacrylate) nanoparticles synthesized by two different techniques. Biomed Papers 148:161–6
31. G.Rothe, G.Valet (1996). Flow cytometric analysis of respiratory burst activity in phagocytes with hydroethidine and 2′,7′-dichlorofluorescin. J Leukoc Biol 47:440–8
32. Z.Rudzki, S.Jothy (1997). CD44 and the adhesion of neoplastic cells. Mol Pathol 50:57–71
33. Y.Shen, Q.Li, J.Tu, J.Zhu (2009). Synthesis and characterization of low molecular weight hyaluronic acid-based cationic micelles for efficient siRNA delivery. Carbohydr Polym 77:95–104
34. V.A.Slepushkin, S.Simoes, P.Dazin,. (1997). Sterically stabilized pH-sensitive liposomes. Intracellular delivery of aqueous contents and prolonged circulation in vivo. J Biol Chem 272:2382–8
35. R.M.Straubinger (1993). pH-sensitive liposomes for delivery of macromolecules into cytoplasm of cultured cells. Methods Enzymol 221:361–76
36. R.M.Straubinger, N.Duzgunes, D.Papahadjopoulos (1985). pH-sensitive liposomes mediate cytoplasmic delivery of encapsulated macromolecules. FEBS Lett 179:148–54
37. P.Sun, D.Zhou, Z.Gan (2011). Novel reduction-sensitive micelles for triggered intracellular drug release. J Control Release 155:96–103
38. V.P.Torchilin (2005). Recent advances with liposomes as pharmaceutical carries. Nat Rev 4:45–60
39. S.Turakhia, C.D.Venkatakrishnan, K.Dunsmore,. (2007). Doxorubicin-induced cardiotoxicity:direct correlation of cardiac fibroblast and H9c2 cell survival and aconitase activity with heat shock protein 27. Am J Physiol Heart Circ Physiol 293:H3111–21
40. K.K.Upadhyay, A.N.Bhatt, A.K.Mishra,. (2010). The intracellular drug delivery and anti tumor activity of doxorubicin loaded poly(g-benzyl L-glutamate)-b-hyaluronan polymersomes. Biomaterials 31:2882–92
41. L.Wasungu, D.Hoekstra (2006). Cationic lipids, lipoplexes and intracellular delivery of genes. J Control Release 116:255–64
42. M.S.Webb, S.W.Hui, P.L.Steponkus (1993). Dehydration-induced lamellar-to-hexagonal-II phase transitions in DOPE/DOPC mixtures. Biochim Biophys Acta 1145:93–104
43. A.K.Yadav, P.Mishra, A.K.Mishra,. (2007). Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin. Nanomedicine 3:246–57
44. F.Yuan, M.Dellian, D.Fukumura,. (1995). Vascular permeability in a human tumor xenograft:molecular size dependence and cutoff size. Cancer Res 55:3752–6
45. C.Zeng, B.P.Toole, S.D.Kinney,. (1998). Inhibition of tumor growth in vivo by hyaluronan oligomers. Int J Cancer 77:396–401
46. C.Zheng, X.Yao, L.Qiu (2011). Novel polymeric vesicles with pH-induced deformation character for advanced drug delivery. Macromol Biosci 11:338–43